LinkedIn Profile

Access Stentys historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:stentys 583279 Dec 3rd, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Dec 3rd, 2020 01:19PM Dec 3rd, 2020 01:19PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Dec 2nd, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Dec 2nd, 2020 04:31PM Dec 2nd, 2020 04:31PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Dec 1st, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Dec 1st, 2020 02:59PM Dec 1st, 2020 02:59PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 30th, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 29th, 2020 09:00PM Nov 30th, 2020 03:50PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 28th, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 28th, 2020 04:36PM Nov 28th, 2020 04:36PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 27th, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 27th, 2020 01:02PM Nov 27th, 2020 01:02PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 26th, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 25th, 2020 07:56PM Nov 25th, 2020 07:56PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 24th, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 24th, 2020 03:28PM Nov 24th, 2020 03:28PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 23rd, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 23rd, 2020 05:17PM Nov 23rd, 2020 05:17PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services
private:stentys 583279 Nov 22nd, 2020 12:00AM STENTYS 3.1K 26.00 Open Medical Device Nov 22nd, 2020 04:14PM Nov 22nd, 2020 04:14PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Stentys Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.